Pharma Journalist -

Genmab A/S announced today that it has entered into a strategic collaboration agreement with Tempus, a privately-owned technology company advancing precision medicine through the…
Read More...

CMAB Biopharma (Suzhou) Inc. ("CMAB"), a pure-play contract development and manufacturing organization (CDMO) specializing in the production of mammalian cell-derived biologic products,…
Read More...

Ridgeback Biotherapeutics LP, a closely held biotechnology company, announced that the Food and Drug Administration has recently granted mAb114, an experimental treatment for Ebola,…
Read More...

Roche announced that the European Commission has approved and granted marketing authorisation for Tecentriq (atezolizumab) in combination with chemotherapy (carboplatin and etoposide)…
Read More...

The U.S. Food and Drug Administration approved Ofev (nintedanib) capsules to slow the rate of decline in pulmonary function in adults with interstitial lung disease associated with…
Read More...

Schrödinger announced a collaboration with AstraZeneca to deploy Schrödinger’s advanced computing platform to help accelerate drug discovery efforts. Schrödinger’s computational…
Read More...

A novel gene therapy treatment for rare inherited eye disorder has been recommended by NICE for use on the NHS. The draft highly specialized technologies guidance recommends…
Read More...

Boehringer Ingelheim and Lupin Limited (Lupin) announced a licensing, development and commercialization agreement for Lupin’s MEK inhibitor compound (LNP3794) as a potential targeted…
Read More...

JSR Life Sciences Companies Selexis SA and KBI Biopharma, Inc. have announced a new collaboration with ZyVersa Therapeutics to advance development of ZyVersa’s lead inflammasome…
Read More...

Accelerated Enrollment Solutions (AES), a business unit of Pharmaceutical Product Development, LLC (PPD), has acquired the clinical research site business of Bioclinica, expanding AES’…
Read More...